The results revealed that decreased SIRT6 was significantly associated with unfavorable OS (P < 0.05) (Fig. 9C) and DFS (P < 0.05) (Fig. 9D) in gastrointestinal tumors (P < 0.05), which validated the results of meta-analysis. This evidence concerns the gene SIRT6 and digestive system neoplasm.